Explore more publications!

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on October 29, 2025

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Natural Health Trends to Report Third Quarter 2025 Financial Results on November 5th
Vaxil Announces Non-Brokered Private Placement
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
STERIS Announces Dividend of $0.63 per share
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025
Seer to Participate in Upcoming November Investor Conferences
Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025
Teladoc Health Reports Third Quarter 2025 Results
BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates
MIMEDX Announces Record Revenue for Third Quarter 2025
Veru Announces Proposed Public Offering

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions